Search

Your search keyword '"Martinez-Sobrido, Luis"' showing total 563 results

Search Constraints

Start Over You searched for: Author "Martinez-Sobrido, Luis" Remove constraint Author: "Martinez-Sobrido, Luis" Language english Remove constraint Language: english
563 results on '"Martinez-Sobrido, Luis"'

Search Results

2. Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants

Catalog

Books, media, physical & digital resources

3. Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective

4. Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle

6. Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

7. Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology

9. SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern

10. A highly efficacious live attenuated mumps virus—based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike

11. SARS-CoV-2 variants evolve convergent strategies to remodel the host response

12. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis

13. Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2

14. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming

17. Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies

18. Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects

19. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike

20. SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics

21. Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera

22. Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents

23. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2

26. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

28. Recombinant Influenza A Viruses Expressing Reporter Genes from the Viral NS Segment.

29. Cellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication.

30. Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights.

36. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets

37. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

40. Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.

41. New Advances on Zika Virus Research.

43. The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease

45. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice

47. New Advances on Zika Virus Research

48. SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.

49. Influenza A virus replicates productively in primary human kidney cells and induces factors and mechanisms related to regulated cell death and renal pathology observed in virusinfected patients.

50. Editorial for SARS-CoV-2 and COVID-19 Topical Collection.